JP7739182B2 - 高濃度タンパク質製剤の粘度を低減させるための低分子量ポリビニルピロリドン（ｐｖｐ）の使用 - Google Patents

高濃度タンパク質製剤の粘度を低減させるための低分子量ポリビニルピロリドン（ｐｖｐ）の使用

Info

Publication number
JP7739182B2
JP7739182B2 JP2021562350A JP2021562350A JP7739182B2 JP 7739182 B2 JP7739182 B2 JP 7739182B2 JP 2021562350 A JP2021562350 A JP 2021562350A JP 2021562350 A JP2021562350 A JP 2021562350A JP 7739182 B2 JP7739182 B2 JP 7739182B2
Authority
JP
Japan
Prior art keywords
pvp
viscosity
composition
antibody
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021562350A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022529996A (ja
JP2022529996A5 (enExample
Inventor
スローイー，クリストファー・ジェームズ
Original Assignee
アムジエン・インコーポレーテツド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アムジエン・インコーポレーテツド filed Critical アムジエン・インコーポレーテツド
Publication of JP2022529996A publication Critical patent/JP2022529996A/ja
Publication of JP2022529996A5 publication Critical patent/JP2022529996A5/ja
Application granted granted Critical
Publication of JP7739182B2 publication Critical patent/JP7739182B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP2021562350A 2019-04-23 2020-04-22 高濃度タンパク質製剤の粘度を低減させるための低分子量ポリビニルピロリドン（ｐｖｐ）の使用 Active JP7739182B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962837647P 2019-04-23 2019-04-23
US62/837,647 2019-04-23
PCT/US2020/029328 WO2020219550A1 (en) 2019-04-23 2020-04-22 The use of low molecular weight polyvinylpyrrolidone (pvp) to reduce viscosity of high concentration protein formulations

Publications (3)

Publication Number Publication Date
JP2022529996A JP2022529996A (ja) 2022-06-27
JP2022529996A5 JP2022529996A5 (enExample) 2023-05-01
JP7739182B2 true JP7739182B2 (ja) 2025-09-16

Family

ID=70614677

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021562350A Active JP7739182B2 (ja) 2019-04-23 2020-04-22 高濃度タンパク質製剤の粘度を低減させるための低分子量ポリビニルピロリドン（ｐｖｐ）の使用

Country Status (8)

Country Link
US (2) US12599669B2 (enExample)
EP (1) EP3958840A1 (enExample)
JP (1) JP7739182B2 (enExample)
CN (1) CN113660927A (enExample)
AU (1) AU2020263318B2 (enExample)
CA (1) CA3141857A1 (enExample)
MX (1) MX2021012782A (enExample)
WO (1) WO2020219550A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS67656B1 (sr) 2018-05-10 2026-02-27 Regeneron Pharma Formulacije koje sadrže visoke koncentracije fuzionog proteina vegf receptora
CN113660927A (zh) 2019-04-23 2021-11-16 安进公司 使用低分子量聚乙烯吡咯烷酮（pvp）降低高浓度蛋白质配制品的黏度
CA3214867A1 (en) * 2021-04-09 2022-10-13 Courtney O'DELL Performance-enhancing excipients and methods of reducing viscosity and increasing stability of biologic formulations

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002516612A (ja) 1997-06-03 2002-06-04 コールター ファーマシューティカル，インコーポレイティド 放射性同位体によって標識されたペプチドのための放射線保護剤
JP2005516971A (ja) 2001-12-21 2005-06-09 ジンマー オーソバイオロジクス，インコーポレイティド ポリペプチド増殖因子のためのポビドン含有担体
JP2010524948A (ja) 2007-04-17 2010-07-22 バクスター・インターナショナル・インコーポレイテッド 球形インスリン微小粒子の肺送達
JP2010248271A (ja) 2002-03-13 2010-11-04 Novartis Ag 医薬微粒子
JP2012512162A (ja) 2008-12-10 2012-05-31 アラーガン、インコーポレイテッド クロストリジウム毒素医薬組成物
US20170209587A1 (en) 2014-07-21 2017-07-27 Board Of Regents, The University Of Texas Sytem Formulations of intraarticular pharmaceutical agents and methods for preparing and using the same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20110097772A (ko) 2008-11-17 2011-08-31 제넨테크, 인크. 생리적 조건하에 거대분자의 응집을 감소시키는 방법 및 제제
BR112013025845A2 (pt) * 2011-04-07 2018-09-04 Glaxosmithkline Llc formulações com viscosidade reduzida
ES2964713T3 (es) * 2014-10-23 2024-04-09 Amgen Inc Reducción de la viscosidad de formulaciones farmacéuticas
CN106511997A (zh) 2015-09-15 2017-03-22 上海抗体药物国家工程研究中心有限公司 一种稳定的蛋白制剂
JP7377596B2 (ja) * 2017-02-22 2023-11-10 アムジエン・インコーポレーテツド 低粘度、高濃度エボロクマブ製剤及びそれらの製造方法
US12103979B2 (en) * 2017-04-28 2024-10-01 Amgen Inc. N-acetylated and non-acetylated dipeptides containing arginine to reduce the viscosity of viscous compositions of therapeutic polypeptides
MA48461A (fr) 2017-04-28 2020-03-04 Amgen Inc Excipients pour réduire la viscosité de formulations d'anticorps et compositions de formulation
CN113660927A (zh) 2019-04-23 2021-11-16 安进公司 使用低分子量聚乙烯吡咯烷酮（pvp）降低高浓度蛋白质配制品的黏度

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002516612A (ja) 1997-06-03 2002-06-04 コールター ファーマシューティカル，インコーポレイティド 放射性同位体によって標識されたペプチドのための放射線保護剤
JP2005516971A (ja) 2001-12-21 2005-06-09 ジンマー オーソバイオロジクス，インコーポレイティド ポリペプチド増殖因子のためのポビドン含有担体
JP2010248271A (ja) 2002-03-13 2010-11-04 Novartis Ag 医薬微粒子
JP2010524948A (ja) 2007-04-17 2010-07-22 バクスター・インターナショナル・インコーポレイテッド 球形インスリン微小粒子の肺送達
JP2012512162A (ja) 2008-12-10 2012-05-31 アラーガン、インコーポレイテッド クロストリジウム毒素医薬組成物
US20170209587A1 (en) 2014-07-21 2017-07-27 Board Of Regents, The University Of Texas Sytem Formulations of intraarticular pharmaceutical agents and methods for preparing and using the same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Pharmaceutical Research，1994年，Vol.11,No.5，pp.624-632

Also Published As

Publication number Publication date
US20220226477A1 (en) 2022-07-21
EP3958840A1 (en) 2022-03-02
WO2020219550A1 (en) 2020-10-29
CN113660927A (zh) 2021-11-16
CA3141857A1 (en) 2020-10-29
JP2022529996A (ja) 2022-06-27
US12599669B2 (en) 2026-04-14
US20260199478A1 (en) 2026-07-16
MX2021012782A (es) 2021-11-25
AU2020263318A1 (en) 2021-10-21
AU2020263318B2 (en) 2025-10-23

Similar Documents

Publication Publication Date Title
JP5631591B2 (ja) 安定な抗体製剤
US12350340B2 (en) Viscosity reduction of highly concentrated protein formulations
KR102385802B1 (ko) Gm-csf 중화 화합물을 포함하는 액체 제제
JP6407174B2 (ja) 抗体の配合物および該配合物の使用
TW201347791A (zh) 抗體調配物
KR102106914B1 (ko) Gm-csf를 중화하는 화합물을 포함하는 액체 제제
JP7842187B2 (ja) 抗体製剤
JP7671697B2 (ja) 安定な低粘度抗体製剤およびその使用
AU2020263318B2 (en) The use of low molecular weight polyvinylpyrrolidone (PVP) to reduce viscosity of high concentration protein formulations
WO2025085401A1 (en) Solid polyacrylamide polymer biopharmaceutical formulations
US20230181471A1 (en) Concentrated compositions of proteins, their preparation and use thereof
WO2024022414A1 (zh) 一种高浓度单克隆抗体制剂及其应用
TW202319398A (zh) 抗體配製物
CN118576542A (zh) 一种稳定的双特异性抗体组合物
TW202606754A (zh) 穩定抗體配製物
HK40110344A (en) Antibody formulations
HK40109865A (en) Stable anti-osmr antibody formulation
WO2025140467A1 (zh) 稳定的高浓度抗pd-1抗体药物制剂
WO2024257040A1 (en) Composition and stable liquid formulations comprising humanized anti-human interleukin 6 (il-6) receptor monoclonal antibodies
EA052347B1 (ru) Композиция, содержащая фрагмент, связывающий антиген pd-l1, и ее применение

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230421

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230421

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240402

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20240626

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20241001

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250128

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250422

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250724

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20250805

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20250903

R150 Certificate of patent or registration of utility model

Ref document number: 7739182

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150